Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach

Oncology

Volumn 64, Issue 3, 2003, Pages 266-274

  Takahashi, Ryoji ^a   Tanaka, Shinji ^a   Kitadai, Yasuhiko ^a   Sumii, Masaharu ^a   Yoshihara, Masaharu ^a   Haruma, Ken ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Gastrointestinal stromal tumor; Microvessel density; Vascular endothelial growth factor; VEGF expression, prognosis

Indexed keywords

KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; LOGISTIC MODELS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; STROMAL CELLS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344375087     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069316     Document Type: Article

References (57)

1. Miettinen M, Sarlomo-Rikala M, Lasota J: Gastrointestinal stromal tumors. Ann Chir Gynaecol 1998;87:278-281.
2. Tazawa K, Tsukada K, Makuuchi H, Tsutsumi Y: An immunohistochemical and clinicopathological study of gastrointestinal stromal tumors. Pathol Int 1999;49:786-798.
3. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ: Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors, correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993;100:428-432.
4. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ: Prognosis of gastrointestinal smooth muscle (stromal) tumors, dependence on anatomic site. Am J Surg Pathol 1999;23:82-87.
5. Chang MS, Choe G, Kim WH, Kim YI: Small intestinal stromal tumors: A clinicopathologic study of 31 tumors. Pathol Int 1998;48:341-347.
6. Hillemanns M, Pasold S, Bottcher K, Hofler H: Prognostic factors of gastrointestinal stromal tumors of the stomach. Verh Dtsch Ges Pathol 1998;82:261-266.
7. Ma CK, De Peralta MN, Amin MB, Linden MD, DeKovich AA, Kubus JJ, Zarbo RJ: Small intestinal stromal tumors: A clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferating antigens. Am J Clin Pathol 1997;108:641-651.
8. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 1986;46:467-473.
9. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
10. Forkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
11. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti C: Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-146.
12. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
13. Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;57:371-374.
14. Porschen R, Classen S, Piontek M, Borchard F: Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res 1994;54:587-591.
15. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33-41.
16. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y: Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-323.
17. Oh-e H, Tanaka S, Kitadai Y, Shimamoto F, Yoshihara M, Haruma K: Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer. Dis Colon Rectum 2001;44:1129-1136.
18. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
19. Shibuya M: Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995;67:281-316.
20. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyper-permeability and angiogenesis. Am J Pathol 1995;146:1029-1039.
21. Klagsbrun M, D'Amore PA: Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1995;7:259-270.
22. Grimmond S, Lagercantz J, Drinkwater C, Silins G, Townson S, Pollock P, Gotley D, Carson E, Rakar S, Nordenskjold M, Ward L, Hayward N, Weber G: Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 1996;6:124-131.
23. Joukov V, Pajusola K, Kaipainen N, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J 1996;15:290-298.
24. Lee J, Gray A, Yuan J, Luoh S, Avraham H, Wood WI: Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt-4. Proc Natl Acad Sci USA 1996;93:1988-1992.
25. Meyer M, Clauss M, Lepple-Wienhues, Waltenberger J, Augustin HG, Ziche M, Lanz C, Bittner M, Rziha HJ, Dehio C: A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J 1999;18:363-374.
26. Olofsson B, Pajusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996;93:2576-2581.
27. Yamada Y, Nezu J, Shimane M, Hirata Y: Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 1997; 42:483-488.
28. Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G, Tahara E: Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 1998;4:2195-2200.
29. Yamamoto S, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G, Tahara E: Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int 1998;48:499-506.
30. Christiane JB, Wenbiao L, Darren WD, Raymond MS, David JM, Michael RW, Corazon DB, Daniel JH, Lee ME: Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 2000;89:488-499.
31. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-3968.
32. Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT). Mod Pathol 2000;13:1134-1142.
33. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary KR, Brigati DJ, Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinoma. Cancer Res 1993;53:937-943.
34. Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ, Fidler IJ: A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J Histochem Cytochem 1993;41:499-506.
35. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-11954.
36. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;5:1806-1814.
37. Reed JA, Manahara LJ, Park CS, Brigati DJ: Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992;13:434-443.
38. Park CS, Brigati DJ, Manahara LJ: Automated molecular pathology: One hour in situ DNA hybridization. J Histotechnol 1991;14:219-229.
39. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54:3242-3247.
40. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
41. Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y, Aozaki K: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995;73:859-863.
42. Plate KH, Breier G, Weich HA: Expression implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;5:4575-4580.
43. Ellis LM, Staley CA, Liu W, Fleming RY, Parikh N, Bucana CD, Gallick GE: Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J Biol Chem 1998;273:1052-1057.
44. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ, Roth JA: Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 1998;58:2288-2292.
45. Takahashi Y, Bucana CD, Cleary KR, Ellis LM: p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 1998;79:34-38.
46. Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D: The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J Biol Chem 1997;272:27509-27512.
47. Akagi Y, Liu W, Zebrowski B, Xie K, Ellis LM: Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res 1998;58:4008-4014.
48. Akagi Y, Liu W, Xie K, Zebrowski B, Shaheen RM, Ellis LM: Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1 β. Br J Cancer 1999;80:1506-1511.
49. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-772.
50. Hong T, Shimada Y, Uchida S, Itami A, Li Z, Ding Y, Kaganoi J, Komoto I, Sakurai T, Imamura M: Expression of angiogenetic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med 2001;8:141-148.
51. Shimamoto T, Haruma K, Tanaka S, Todo H, Yoshihara M, Sumii K, Kajiyama G: Usefulness of nucleolar organizer region staining in gastric myogenic tumors: Correlation with ploidy by DNA flow cytometry. Oncology 1993;50:52-56.
52. Shimamoto T, Haruma K, Sumii K, Kajiyama G, Tahara E: Flow cytometric DNA analysis of gastric smooth muscle tumors. Cancer 1992;70:2031-2034.
53. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V: Prognosis significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 1997;28:160-165.
54. Al-Bozom IA: p53 expression in gastrointestinal stromal tumors. Pathol Int 2001;51:519-523.
55. Lopes JM, Silva P, Seixas M, Cirnes L, Seruca R: Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumors. Histopathology 1998;33:576-587.
56. Sakurai S, Fukayama M, Kaizaki Y, Saito K, Kanazawa K, Kitamura M, Iwasaki Y, Hishima T, Koike M: Telomerase activity in gastrointestinal stromal tumors. Cancer 1998;83: 2060-2066.
57. Nishida T, Hirota S: Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15:1293-1301.